Literature DB >> 19220828

Clinical Immunology Review Series: An approach to the patient with angio-oedema.

S Grigoriadou1, H J Longhurst.   

Abstract

Angio-oedema is a common reason for attendance at the accident and emergency department and for referral to immunology/allergy clinics. Causative factors should always be sought, but a large proportion of patients have the idiopathic form of the disease. A minority of patients represent a diagnostic and treatment challenge. Failure to identify the more unusual causes of angio-oedema may result in life-threatening situations. Common and rare causes of angio-oedema will be discussed in this article, as well as the diagnostic and treatment pathways for the management of these patients. A comprehensive history and close monitoring of response to treatment are the most cost-effective diagnostic and treatment tools.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19220828      PMCID： PMC2669512          DOI： 10.1111/j.1365-2249.2008.03845.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  122 in total

1.  Local bradykinin generation in hereditary angioedema.

Authors:  J Nussberger; M Cugno; M Cicardi; A Agostoni
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

2.  [Gleich's syndrome].

Authors:  S Emonet; G Kaya; C Hauser
Journal:  Ann Dermatol Venereol       Date:  2000 Jun-Jul       Impact factor: 0.777

3.  Bradykinin-mediated angioedema.

Authors:  Juerg Nussberger; Massimo Cugno; Marco Cicardi
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

4.  Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema.

Authors:  H Farkas; G Harmat; P N Kaposi; I Karádi; B Fekete; G Füst; K Fáy; A Vass; L Varga
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 2.566

5.  Angiotensin-converting enzyme inhibitor-induced angioedema: late onset, irregular course, and potential role of triggers.

Authors:  P I Schiller; S L Messmer; W E Haefeli; R G Schlienger; A J Bircher
Journal:  Allergy       Date:  1997-04       Impact factor: 13.146

6.  Incidence and characteristics of angioedema associated with enalapril.

Authors:  John B Kostis; Harold J Kim; James Rusnak; Thomas Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Journal:  Arch Intern Med       Date:  2005-07-25

7.  Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease.

Authors:  D E Dean; D L Schultz; R H Powers
Journal:  J Forensic Sci       Date:  2001-09       Impact factor: 1.832

Review 8.  Aspirin and NSAID sensitivity.

Authors:  Donald D Stevenson
Journal:  Immunol Allergy Clin North Am       Date:  2004-08       Impact factor: 3.479

Review 9.  An approach to the patient with urticaria.

Authors:  S J Deacock
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

10.  The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738
View more
  11 in total

1.  Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts.

Authors:  Marco Cicardi; Paolo Bellis; Giuliano Bertazzoni; Mauro Cancian; Maurizio Chiesa; Paolo Cremonesi; Pietro Marino; Nicola Montano; Claudia Morselli; Francesco Ottaviani; Roberto Perricone; Massimo Triggiani; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2013-09-04       Impact factor: 3.397

2.  Hereditary angioedema: New therapeutic options for a potentially deadly disorder.

Authors:  Frank J Eidelman
Journal:  BMC Blood Disord       Date:  2010-05-14

3.  Complexity of case mix in a regional allergy service.

Authors:  Edward R Kaminski; Claire A Bethune; Ray B Jones
Journal:  BMC Res Notes       Date:  2012-02-17

4.  C1 inhibitor deficiency: 2014 United Kingdom consensus document.

Authors:  H J Longhurst; M D Tarzi; F Ashworth; C Bethune; C Cale; J Dempster; M Gompels; S Jolles; S Seneviratne; C Symons; A Price; D Edgar
Journal:  Clin Exp Immunol       Date:  2015-05-13       Impact factor: 4.330

5.  Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions.

Authors:  Jennifer W Leiding; Douglas Beakes; Stephen C Dreskin; Anete Grumach; Michihiro Hide; Avner Reshef; Massimo Triggiani; Michael A Kaliner
Journal:  World Allergy Organ J       Date:  2014-01-22       Impact factor: 4.084

Review 6.  Pathogenesis of Drug Induced Non-Allergic Angioedema: A Review of Unusual Etiologies.

Authors:  Junior Kalambay; Haider Ghazanfar; Karen A Martes Pena; Ruhul A Munshi; George Zhang; Jay Y Patel
Journal:  Cureus       Date:  2017-08-23

7.  The characteristics of upper airway edema in hereditary and acquired angioedema with C1-inhibitor deficiency.

Authors:  Zsuzsanna Balla; Noémi Andrási; Zsófia Pólai; Beáta Visy; Ibolya Czaller; György Temesszentandrási; Dorottya Csuka; Lilian Varga; Henriette Farkas
Journal:  Clin Transl Allergy       Date:  2021-12       Impact factor: 5.871

8.  Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor.

Authors:  Lourdes Pastó Cardona; Ramon Lleonart Bellfill; Joaquim Marcoval Caus
Journal:  Appl Clin Genet       Date:  2010-12-03

9.  The impact of duration of treatment on reported time-to-onset in spontaneous reporting systems for pharmacovigilance.

Authors:  Ghazaleh Karimi; Kristina Star; G Niklas Norén; Staffan Hägg
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

10.  ACE-I Angioedema: Accurate Clinical Diagnosis May Prevent Epinephrine-Induced Harm.

Authors:  R Mason Curtis; Sarah Felder; Rozita Borici-Mazi; Ian Ball
Journal:  West J Emerg Med       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.